Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position.
about
Oridonin, a Promising ent-Kaurane Diterpenoid Lead CompoundMolecular Insight in the Multifunctional Effects of OridoninDiscovery and development of natural product oridonin-inspired anticancer agentsent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoidsOridonin inhibits hepatic stellate cell proliferation and fibrogenesis.Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agentsEnhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis.Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.Diterpenoids of terrestrial origin.Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects.Generating skeletal diversity from the C19 -diterpenoid alkaloid deltaline: a ring-distortion approach.Synthesis of locked cyclohexene and cyclohexane nucleic acids (LCeNA and LCNA) with modified adenosine units
P2860
Q26738633-D345B549-A6CC-44D5-823A-CD9A6CC498C5Q26796359-B7924A5F-E4C4-435B-AC46-6DB0E8902409Q28387804-5693FC9F-5F20-4AD2-B62C-51100F93367FQ34315800-7903CE64-593A-4742-B3D1-B8306D56947EQ34479065-51257A4F-C18B-4593-82C9-67CECAC787A7Q35108020-7BD8B924-154B-42AD-A231-B7D40C65E4CCQ36259454-18FA5849-9AC6-4DD8-A4D1-0CEE41FC3FEEQ37432505-951903BD-1A83-48A3-9E12-1F8259944330Q37636708-22F3626A-B508-47D1-9C19-F0C0DDA0382CQ38256088-BB16C886-C322-4D65-9656-A86B5770D296Q38837216-A72484CF-88A1-4161-94C2-C2F6795B8DEEQ39007335-172D300E-822B-4A53-BF93-55332F47E62BQ50980050-525B84DB-18CA-4D57-AF51-69D1834FDBDEQ56791584-BCAC207E-CC64-46F9-97F1-9D961D6E4F6B
P2860
Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@ast
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@en
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@nl
type
label
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@ast
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@en
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@nl
prefLabel
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@ast
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@en
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@nl
P2093
P2860
P356
P1433
P1476
Overcoming synthetic challenge ...... the C-1, C-2, or C-3 position.
@en
P2093
Christopher Wild
Chunyong Ding
Haijun Chen
Mark A White
Qiang Shen
Tianzhi Wang
Yusong Zhang
P2860
P304
P356
10.1021/OL4015865
P407
P577
2013-07-08T00:00:00Z